DOI QR코드

DOI QR Code

Acute toxicity test and safety classification for Termitomyces albuminosus containing pharmacologically similar ingredient of Aconitum koreanum

백부자-대체 가능 한약재의 계종버섯에 대한 급성독성시험과 안전성등급화

  • An, Minji (Department of Toxicity assessment & GLP Center, Daegu Catholic University) ;
  • Park, Yeongchul (Department of Toxicity assessment & GLP Center, Daegu Catholic University)
  • 안민지 (대구가톨릭대학교 GLP 센터 & 화학물질독성평가학과) ;
  • 박영철 (대구가톨릭대학교 GLP 센터 & 화학물질독성평가학과)
  • Received : 2017.06.23
  • Accepted : 2017.07.15
  • Published : 2017.07.30

Abstract

Objectives : Termitomyces albuminosus (Berk.) Heim is one of the famous wild edible mushrooms in the southern part of China. It is known that Termitomyces albuminosus, like Aconitum koreanum used in Korean traditional medicine, contains a kind of cerebroside, termitomycesphin, causing a pharmacologic effect on the neuron system. The pharmacologic effect of Termitomyces albuminosus can be used to possibly replace Aconitum koreanum. However, It needs to be certified as safe before it can be used. Here, a single-oral toxicity test and safety classification was conducted to obtain acute information of the toxicity of dried-Termitomyces albuminosus powder and to secure its safety in clinical applications. Methods : In order to calculate approximate lethal dose(ALD), test substance was orally administered to male and female SD-rat at dose levels of 5,000 and 0 (vehicle control) mg/kg (body weight). Based on the result of this toxicity, also the estimation of safety classification was calculated using the HED-based (human equivalent dose) MOS (margin of safety). Results : There were no mortalities, test substances treatment-related clinical signs, no changes in the body or organ weights, and no gross or histopathological findings at 14 days after treatment with test substance. Thus, the approximate lethal dose of dried-Termitomyces albuminosus powder was considered over 5,000 mg/kg in both female and male mice. Conclusions : Based on the limit dose, 5000 mg/kg, it was estimated that dried-Termitomyces albuminosus powder is classified as "Specified class B" indicating that clinical dose is not limited to patients as safe as food.

Keywords

References

  1. Chinese Pharmacopoeia Commission. Pharmacopoeia of People's Republic of China. China : 2010 ; 98-99.
  2. Chi S, Cai W, Liu P, Zhang Z, Chen X, Gao L, Qi J, Bi L, Z Chen, Qi Z. Baifuzi reduces transient ischemic brain damage through an interaction with the STREX domain of BKCa channels. Cell Death Dis. 2010 ; 1 : e13. https://doi.org/10.1038/cddis.2009.10
  3. Zhou L, Zhang YJ, Gao LJ, Ye Y, Qi JH, Qi Z. Structureeactivity relationship of Baifuzi-cerebrosides on BKCa channel activation. European Journal of Medicinal Chemistry. 2014 ; 75 : 301-307. https://doi.org/10.1016/j.ejmech.2014.01.007
  4. Coetzee T, Fujita N, Dupree J, Shi R, Andrew B, Kinuko S, Kunihiko S, Brian P. Myelination in the Absence of Galactocerebroside and Sulfatide: Normal Structure with Abnormal Function and Regional Instability. Cell. 1996 ; 86 : 209-219. https://doi.org/10.1016/S0092-8674(00)80093-8
  5. Ezoe T, Vanier MT, Oya Y, Popko B, Tohyama J, Matsude J, Suzuki K, Suzuki K. Biochemistry and neuropathology of mice doubly deficient in synthesis and degradation of galactosylceramide. Journal of Neurosci Research. 2000 ; 59 : 170-178. https://doi.org/10.1002/(SICI)1097-4547(20000115)59:2<170::AID-JNR3>3.0.CO;2-G
  6. Rao RP, Acharya JK. Sphingolipids and membrane biology as determined from genetic models. Prostaglandins Other Lipid Mediat. 2008 ; 85(1-2) : 1-16. https://doi.org/10.1016/j.prostaglandins.2007.10.002
  7. Jurevics H, Hostettler J, Muse ED, Sammond DW, Matsushima GK, Toews AD, Morell P. Cerebroside synthesis as a measure of the rate of remyelinationfollowing cup rizone-induced demyelination in brain. J Neurochem. 2001 ; 77 : 1067-1076. https://doi.org/10.1046/j.1471-4159.2001.00310.x
  8. Yanagihara T, Cumings JN. Fatty acid composition of cerebrosides and cerebroside sulphatides in cerebral oedema. Acta Neuropathologica. 1969 ; 12(1) : 62-67. https://doi.org/10.1007/BF00685311
  9. Qi JH, Ojika M, Sakagami YJ. Termitomycesphins A -D, Novel Neurito genic Cerebrosides from the Edible Chinese Mushroom Termitomyces albuminosus. Tetra hedron. 2000 ; 56(32) : 5835-5841. https://doi.org/10.1016/S0040-4020(00)00548-2
  10. Qu Y, Sun K, Gao L, Sakagami Y, Kawagishi H, Ojika M, Qi J. Termitomyce sphins G and H, Additional Cerebrosides from the Edible Chinese Mushroom Termitomyces albuminosus. Bioscience, Biotechnology, and Biochemistry. 2012 ; 76 : 791-793. https://doi.org/10.1271/bbb.110918
  11. Qi JH, Ojika M, Sakagami Y. Neuritogenic cerebrosides from an edible chinese mushroom. Part 2: structures of two additional termitomycesphins and activity enhancement of an inactive cerebroside by hydroxylation. Bioorganic & Medicinal Chemistry. 2001 ; 9(8) : 2171-2177. https://doi.org/10.1016/S0968-0896(01)00125-0
  12. Park YS, Lee SD. Evidence-based approach for herbal medicine-safety classification: Human equivalent dose-based the margin of safety. 2013 ; 17(3) : 1-12.
  13. Park YC, Lee SD. Introduction of evidence-based practical medicine through safety classification for herbal medicine(1). Journal of Korean Oriental Medicine. 2014 ; 35(1) : 114-123. https://doi.org/10.13048/jkm.14011
  14. Park YC, Lee SD. Safety classification for frequentlyused herbal medicines inducing toxic metabolites. Journal of Korean Oriental Medicine. 2015 ; 19(2) : 123-133.
  15. Park YC, Lee SD. Toxicity and safety classification of 4 animal medicines - Focusing on venoms from bee, snake, blister beetle and scolopendrid -. Journal of Korean Oriental Medicine. 2016 ; 20(1) : 125-144.
  16. Vit PJ. Approximate lethal dose versus median lethal dose in acute toxicity testing of pharmaceuticals. A retrospective study. Arch Toxicol. 1989 ; 63(4) : 343-4. https://doi.org/10.1007/BF00278650
  17. legislation of Ministry of food and Drug safety. Food and Drug Regulations in korea. Available from : URL : http://www.mfds.go.kr/index.do ?x=0&searchkey=notice_number&mid=1013&searchword=2015-82%C8%A3&y=0&division=&pageNo=1&seq=10128&cmd=v.
  18. An MJ, Heo HS, Lee JS, Son HY, Lim HO, Park GB, Lee JH, Jee JG, Park YC. Repeated Dose 90-Day Oral Toxicity Study of Dried Thermitomyces albuminosus Powder in Rats. Journal of Life Science 2016 ; 26(10) : 1153-1162. https://doi.org/10.5352/JLS.2016.26.10.1153
  19. FDA. Guidance for Industry: Estimating the Maximum Safe Starting Dose in Initial Clinical Trials for Therapeutics in Adult Healthy Volunteers. Rockville MD : FDA. 2005.